Patent watchdog firm Troll Busters has chosen to abandon its lawsuit against more than a dozen life science companies for false patent marking related to various nucleic acid detection, amplification, and cloning technologies, according to recently filed court documents.
The US District Court for the Southern District of California, which had been hearing the case, last week granted Troll Busters' motion to dismiss, which was filed earlier in October.
Troll Busters decided to bring an end to the lawsuit after it was informed by the court in September that it would fully dismiss the case unless Troll Busters could amend certain deficiencies in its complaint, such as the citation of specific instances of false marking, within 30 days (PCR Insider, 9/15/11).
Troll Busters had alleged that the companies — Roche Molecular Systems, Roche Applied Sciences, Roche Diagnostics, Clontech Laboratories, Integrated DNA Technologies, Life Technologies, Qiagen, Thermo Fisher Scientific, Quanta Biosciences, Gene Link, GenScript, EMD Chemicals, TriLink Bio Technologies, Cepheid, and Eurogentec — falsely marked various nucleic acid detection, amplification, and cloning technologies as being patented after the relevant patents expired.